You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 10,335,462


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,335,462
Title:Use of long-acting GLP-1 peptides
Abstract: The invention relates to use of long-acting GLP-1 peptides in certain dosage regimes for the treatment of type 2 diabetes, obesity, etc.
Inventor(s): Jensen; Christine Bjoern (Charlottenlund, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:15/656,042
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,335,462
Patent Claims: 1. A method for treating type 2 diabetes, comprising administering semaglutide once weekly in an amount of 1.0 mg to a subject in need thereof.

2. The method according to claim 1, wherein the semaglutide is administered by parenteral administration.

3. The method according to claim 2, wherein the solution is administered by subcutaneous injection.

4. The method according to claim 1, wherein the semaglutide is administered in the form of an isotonic aqueous solution comprising phosphate buffer at a pH in the range of 7.0-9.0.

5. The method according to claim 4, wherein the solution further comprises propylene glycol and phenol.

6. The method according to claim 4, wherein the pH is 7.4.

7. The method according to claim 6, wherein the solution further comprises propylene glycol and phenol.

8. The method according to claim 4, wherein the phosphate buffer is a sodium dihydrogen phosphate buffer.

9. The method according to claim 1, wherein the semaglutide is administered by subcutaneous injection in the form of an isotonic aqueous solution comprising at a sodium dihydrogen phosphate buffer at a pH in the range of 7.0-9.0, and wherein the solution further comprises propylene glycol and phenol.

10. The method according to claim 9, wherein the pH is 7.4.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.